RIPK1 and Zika virus infectious disease: Recent work in a mouse central nervous system model of ZIKV infection indicated RIPK1 signaling directed a “metabolic reprogramming” in infected neurons characterized by inhibition of succinate dehydrogenase, which suppressed viral replication (78), suggesting RIPK1-controlled activities might have anti-viral effects.